Arkolith/Insider Trading/LENZ/Form 4

Olsson Shawn

Chief Commercial OfficerLENZ Therapeutics, Inc. (LENZ) · full profile →Form 4 · filed Nov 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$261K
Net Open-Market Flow
-$261K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2025Option exercise(M)10K$2.08$21K15K
Nov 17, 2025Sell(S)4K$25.74$108K11K
Nov 17, 2025Sell(S)6K$26.37$153K5K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 17, 2025Option exercise(M)10K—$053K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002015796-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML